Monthly information on share capital and company voting rights

Rhea-AI Summary

Cellectis has released its monthly share capital and voting rights update as of January 31, 2025, in accordance with Article 223-16 of the French financial markets authority's General Regulation. The company reported a total of 100,093,873 shares in capital and 88,660,571 voting rights. This information was disclosed for the Euronext Growth market, where Cellectis trades under the ISIN code FR0010425595.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, Feb. 04, 2025 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
01/31/2025	100,093,873	88,660,571

For further information on Cellectis, please contact:     

Media contact:       

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contacts:       

Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com 

Attachment

• Voting_Rights_PR_January_2025_EN

FAQ

How many shares does Cellectis (CLLS) have in circulation as of January 2025?

As of January 31, 2025, Cellectis has 100,093,873 shares in total capital.

What is the total number of voting rights for CLLS stock as of January 2025?

Cellectis reported 88,660,571 total voting rights as of January 31, 2025.

What is the difference between CLLS total shares and voting rights in January 2025?

There is a difference of 11,433,302 between the total number of shares (100,093,873) and voting rights (88,660,571).

On which exchange market are CLLS shares listed according to the January 2025 update?

Cellectis shares are listed on the Euronext Growth market.